Table 2. Treatment protocols for arms in current study.

Arm	Treatment Protocol
KPT-9274	Anti-CD20 20mg/kg IV q3 weeks for 4 doses
	Doxorubicin 25mg/m2 IV q3 weeks for 4 doses
	KPT-9274 4mg/kg PO q3 weeks for 4 doses
TAK-981	Anti-CD20 10-20mg/kg IV q1 week for 4 doses
	Doxorubicin 25mg/m2 IV once on day 0
	TAK-981 2.5-3mg/kg IV q1 week for 4 doses
RV1001	Anti-CD20 10-20mg/kg IV q3 weeks for 4 doses
	Doxorubicin 20-25mg/m2 IV q3 weeks for 4 doses
	RV1001 10mg/kg PO q24h 4 days on, 3 days off, weekly (12 weeks total or until disease progression)